Related Experiment Video
Updated: Feb 18, 2026

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Outcome after heart transplantation from donation after circulatory-determined death donors
Simon Messer1, Aravinda Page1, Richard Axell1
1Department of Transplantation, Papworth Hospital National Health Service Foundation Trust, Papworth Everard, Cambridgeshire, United Kingdom.
Insights
Heart transplants from donation after circulatory-determined death (DCD) donors show similar 90-day survival rates compared to donation after brain death (DBD) donors. This approach can expand the donor pool for heart transplantation.
Area of Science:
- Cardiology
- Transplantation Medicine
- Surgical Innovation
Background:
- The demand for heart transplants significantly exceeds the supply of donor hearts from donation after brain death (DBD).
- Donation after circulatory-determined death (DCD) presents a potential supplementary source of donor hearts.
- This study evaluates the largest single-center experience comparing DCD and DBD heart transplant outcomes.
Purpose of the Study:
- To compare the outcomes of heart transplantation using DCD donors versus matched DBD donors.
- To assess the viability of DCD heart donation as an additive strategy to increase heart transplant activity.
Main Methods:
- A retrospective analysis of 28 DCD heart transplants was conducted.
- DCD hearts were retrieved using normothermic regional perfusion (NRP) or direct procurement and perfusion (DPP).
- Outcomes were compared against a matched cohort of DBD heart transplants, with 90-day survival as the primary endpoint.
Main Results:
- Ninety-day survival rates were comparable between DCD (92%) and DBD (96%) recipients (p = 1.0).
- Hospital length of stay, rejection episodes, allograft function, and 1-year survival (DCD 86%, DBD 88%) were similar between groups.
- The retrieval method (NRP vs. DPP) did not impact transplant outcomes.
Conclusions:
- Heart transplantation from DCD donors yields comparable short-term outcomes to traditional DBD heart transplants.
- DCD heart donation is a viable strategy to increase heart transplant activity in selected patients.
Background:
The requirement for heart transplantation is increasing, vastly outgrowing the supply of hearts available from donation after brain death (DBD) donors. Transplanting hearts after donation after circulatory-determined death (DCD) may be a viable additive alternative to DBD donors. This study compared outcomes from the largest single-center experience of DCD heart transplantation against matched DBD heart transplants.
Methods:
DCD hearts were retrieved using normothermic regional perfusion (NRP) or direct procurement and perfusion (DPP). During NRP, perfusion was restored to the arrested heart within the donor with the exclusion of the cerebral circulation, whereas DPP hearts were removed directly. All hearts were maintained on machine perfusion during transportation. A retrospective cohort of DBD heart transplants, matched for donor and recipient characteristics, was used as a comparison group. The primary outcome measure of this study (set by the United Kingdom regulatory body) was 90-day survival.
Results:
There were 28 DCD heart transplants performed during the 25-month study period. Survival at 90 days was not significantly different between DCD and matched DBD transplant recipients (DCD, 92%; DBD, 96%; p = 1.0). Hospital length of stay, treated rejection episodes, allograft function, and 1-year survival (DCD, 86%; DBD, 88%; p = 0.98) were comparable between groups. The method of retrieval (NRP or DPP) was not associated with a difference in outcome.
Conclusions:
These results suggest that heart transplantation from DCD heart donation provides comparable short-term outcomes to traditional DBD heart transplants and can serve to increase heart transplant activity in well-selected patients.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

